InMed Pharmaceuticals (INM) Assets: 2021-2025
Historic Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $13.4 million.
- InMed Pharmaceuticals' Assets rose 27.67% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 27.67%. This contributed to the annual value of $15.6 million for FY2025, which is 31.78% up from last year.
- InMed Pharmaceuticals' Assets amounted to $13.4 million in Q3 2025, which was down 14.24% from $15.6 million recorded in Q2 2025.
- Over the past 5 years, InMed Pharmaceuticals' Assets peaked at $19.4 million during Q4 2021, and registered a low of $8.5 million during Q4 2024.
- Its 3-year average for Assets is $12.5 million, with a median of $13.4 million in 2024.
- Per our database at Business Quant, InMed Pharmaceuticals' Assets crashed by 44.27% in 2024 and then soared by 31.78% in 2025.
- InMed Pharmaceuticals' Assets (Quarterly) stood at $19.4 million in 2021, then decreased by 12.71% to $16.9 million in 2022, then declined by 9.84% to $15.3 million in 2023, then tumbled by 44.27% to $8.5 million in 2024, then grew by 27.67% to $13.4 million in 2025.
- Its Assets was $13.4 million in Q3 2025, compared to $15.6 million in Q2 2025 and $9.3 million in Q1 2025.